Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on Feb 22, 2012.
Shortage details
- Status
- Current
- Company
- Amphastar Pharmaceuticals, Inc.
- Package NDC
- 76329-3390-1
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)
- Initial Posting
- Feb 22, 2012